The 2 Minute Medicine® Podcast

We begin with a discussion about our article of the week which comes from The Lancet and is entitled “Efficacy and safety of the muscarinic receptor agonist KarXT (xanomeline–trospium) in schizophrenia (EMERGENT-2) in the USA: results from a randomised, double-blind, placebo-controlled, flexible-dose phase 3 trial.” Then we discuss the challenges and recovery after having brain aneurysm and talk about the first disease modifying FDA approved drug for Alzheimer’s disease. After that, we take a look at liver transplant in children. Finally, we go over psoriasis and briefly go over risk factors and treatments.

We begin this episode by discussing our article of the week which comes from the New England Journal of Medicine and is entitled “Apixaban for stroke prevention in subclinical atrial fibrillation”. In the second half of the episode, we begin with a discussion about stroke in young patients with Lupus. Then we discuss how Starting January 29th British Columbia began providing Canada’s first-at-home self HPV screening test kits for cervical cancer. Last but not least, we take a closer look at acne, current treatments, and a possible vaccine that has shown promise in mouse models, and conclude with a conversation about opioids.

We begin this episode by discussing our article of the week which comes from the BMC Nutrition Journal and is entitled “Clusters of carbohydrate-rich foods and associations with type 2 diabetes incidence: a prospective cohort study.” We begin with a discussion about blood donation, and the decline we are seeing in blood donors. Then we take a closer look at lead poisoning in the context of a recent recall of contaminated cinnamon applesauce products. After that, we investigate multiple sclerosis and how it can affect one’s life. Finally, we discuss the cold winter temperatures, the risks of the cold, and how we can stay safe this winter.

In this episode, we begin by discussing our article of the week which comes from the New England Journal of Medicine and is entitled “Teplizumab and beta-cell function in newly diagnosed type 1 diabetes.” Then we take a closer look at allergies and new treatments on the horizon for food allergies. Next, a discussion about lung cancer, following the recent passing of Andre Braugher. Last but not least, we discuss New Year’s resolutions along with evidence-based ways to make them last and explore the rise in cases of counterfeit Ozempic use, and how this has affected the world. We are excited to share that the highly anticipated 2nd edition of our Classics in Medicine book is now available in stores and on Amazon! Buy your copy today at: ⁠⁠⁠⁠https://bit.ly/2zZnJt9

We begin this episode by discussing our article of the week from the Annals of Internal Medicine and is entitled “Cardiovascular health of middle-aged US adults by income level, 1999 to March 2020: A serial cross-sectional study.” In the second half, we begin by discussing an increasingly popular procedure used in infants who are struggling with breastfeeding. Then we delve into the new findings that a hormone, GDF15, is linked to morning sickness. After this, we discuss ketamine, the drug that was implicated in the tragic passing of 'Friends' star Matthew Perry. Finally, we end with a conversation about the ongoing generic drug shortages occurring across the country.  We are excited to share that the highly anticipated 2nd edition of our Classics in Medicine book is now available in stores and on Amazon! Buy your copy today at: ⁠⁠⁠⁠https://bit.ly/2zZnJt9

We begin this episode by discussing our article of the week from the New England Journal of Medicine, entitled “Trial of Botulinum Toxin for Isolated or Essential Head Tremor”. In the second half, we discuss how as semaglutide, also known by brand names Ozempic or Wegovy, continues to make headlines, a new drug called Zepbound is entering the weight loss sphere. Next, we discuss organ transplants and a new antibiotics developed for the treament of  gonorrhea, Zoliflodacin. Last but not least, we discuss why ⁠March of Dimes⁠, a maternal and infant health organization, issued ⁠a D+ to the USA⁠ for the 2nd year in a row for its relatively high rate of preterm births.  We are excited to share that the highly anticipated 2nd edition of our Classics in Medicine book is now available in stores and on Amazon! Buy your copy today at: ⁠⁠⁠⁠⁠https://bit.ly/2zZnJt9⁠

We begin this episode by discussing our article of the week from the New England Journal of Medicine, entitled “Sarilumab for Relapse of Polymyalgia Rheumatica during Glucocorticoid Taper”. Next, in the second half, we begin by discussing the UK's approval of the first licensed medication using CRISPR technology. Next, we will dive into the American Heart Association's decision to remove race as one of the biological risk factors for cardiovascular disease in their cardiac risk algorithm. Then we will discuss the news of NBA player CJ McCollum's pneumothorax, and finally we will end with a conversation about a recent finding that the life expectancy gap between men and women has widened. We are excited to share that the highly anticipated 2nd edition of our Classics in Medicine book is now available in stores and on Amazon! Buy your copy today at: ⁠⁠⁠https://bit.ly/2zZnJt9

We begin this episode by discussing our article of the week from Pediatrics, entitled “HIV Preexposure Prophylaxis Provision among Adolescents: 2018 to 2021”.  We then dive deeper into a discussion about seasonal affective disorder, its treatment, and its impact on the population. Then we take a closer look at the Movember movement and how it relates to men’s health. After that, we discuss the recent surge in syphilis cases and what can be done about it. Last, but not least, we have a conversation about substance use disorders in the wake of Matthew Perry’s passing. We are excited to share that the highly anticipated 2nd edition of our Classics in Medicine book is now available in stores and on Amazon! Buy your copy today at: ⁠⁠https://bit.ly/2zZnJt9

We begin this episode by discussing our article of the week from Pediatrics, entitled “COVID-19 Vaccine Hesitancy Among Parents: A Qualitative Study”. In the second half of our episode, we start off by discussing the issue of performance-enhancing drugs in sports following the news of a  banned substance scandal in the men's marathon. Next, we will dive into the NHL's Pride Tape ban and their decision to reverse the ban following public push-back. Finally, we end with conversations about the bedbug outbreak in Paris, and new studies highlighting the value of wearable technology in diagnosing and monitoring Parkinson's disease. We are excited to share that the highly anticipated 2nd edition of our Classics in Medicine book is now available in stores and on Amazon! Buy your copy today at: ⁠https://bit.ly/2zZnJt9

We begin this episode by discussing our article of the week from the New England Journal of Medicine, entitled ““Increasing Prevalence of Artemisinin-Resistant HRP2-Negative Malaria in Eritrea.” In the second half of our episode, we begin by taking a closer look at the public heath crisis in Gaza. Next, we discuss a recently published study in JAMA, and examine the possible link between ADHD and Dementia. Last but not least, a short discussion about the significance of October being National Pregnancy and Infant Loss Awareness Month. We are excited to share that the highly anticipated 2nd edition of our Classics in Medicine book is now available in stores and on Amazon! Buy your copy today at: https://bit.ly/2zZnJt9